Copyright Reports & Markets. All rights reserved.

Global Growth Hormone Disorder Treatment Market Growth 2022-2028

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Growth Hormone Disorder Treatment Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for Growth Hormone Disorder Treatment by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for Growth Hormone Disorder Treatment by Country/Region, 2017, 2022 & 2028
  • 2.2 Growth Hormone Disorder Treatment Segment by Type
    • 2.2.1 Growth Hormone Stimulator
    • 2.2.2 Growth Hormone Inhibitor
  • 2.3 Growth Hormone Disorder Treatment Sales by Type
    • 2.3.1 Global Growth Hormone Disorder Treatment Sales Market Share by Type (2017-2022)
    • 2.3.2 Global Growth Hormone Disorder Treatment Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global Growth Hormone Disorder Treatment Sale Price by Type (2017-2022)
  • 2.4 Growth Hormone Disorder Treatment Segment by Application
    • 2.4.1 Dwarfism
    • 2.4.2 Gigantism
    • 2.4.3 Other
  • 2.5 Growth Hormone Disorder Treatment Sales by Application
    • 2.5.1 Global Growth Hormone Disorder Treatment Sale Market Share by Application (2017-2022)
    • 2.5.2 Global Growth Hormone Disorder Treatment Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global Growth Hormone Disorder Treatment Sale Price by Application (2017-2022)

3 Global Growth Hormone Disorder Treatment by Company

  • 3.1 Global Growth Hormone Disorder Treatment Breakdown Data by Company
    • 3.1.1 Global Growth Hormone Disorder Treatment Annual Sales by Company (2020-2022)
    • 3.1.2 Global Growth Hormone Disorder Treatment Sales Market Share by Company (2020-2022)
  • 3.2 Global Growth Hormone Disorder Treatment Annual Revenue by Company (2020-2022)
    • 3.2.1 Global Growth Hormone Disorder Treatment Revenue by Company (2020-2022)
    • 3.2.2 Global Growth Hormone Disorder Treatment Revenue Market Share by Company (2020-2022)
  • 3.3 Global Growth Hormone Disorder Treatment Sale Price by Company
  • 3.4 Key Manufacturers Growth Hormone Disorder Treatment Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Growth Hormone Disorder Treatment Product Location Distribution
    • 3.4.2 Players Growth Hormone Disorder Treatment Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Growth Hormone Disorder Treatment by Geographic Region

  • 4.1 World Historic Growth Hormone Disorder Treatment Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global Growth Hormone Disorder Treatment Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global Growth Hormone Disorder Treatment Annual Revenue by Geographic Region
  • 4.2 World Historic Growth Hormone Disorder Treatment Market Size by Country/Region (2017-2022)
    • 4.2.1 Global Growth Hormone Disorder Treatment Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global Growth Hormone Disorder Treatment Annual Revenue by Country/Region
  • 4.3 Americas Growth Hormone Disorder Treatment Sales Growth
  • 4.4 APAC Growth Hormone Disorder Treatment Sales Growth
  • 4.5 Europe Growth Hormone Disorder Treatment Sales Growth
  • 4.6 Middle East & Africa Growth Hormone Disorder Treatment Sales Growth

5 Americas

  • 5.1 Americas Growth Hormone Disorder Treatment Sales by Country
    • 5.1.1 Americas Growth Hormone Disorder Treatment Sales by Country (2017-2022)
    • 5.1.2 Americas Growth Hormone Disorder Treatment Revenue by Country (2017-2022)
  • 5.2 Americas Growth Hormone Disorder Treatment Sales by Type
  • 5.3 Americas Growth Hormone Disorder Treatment Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Growth Hormone Disorder Treatment Sales by Region
    • 6.1.1 APAC Growth Hormone Disorder Treatment Sales by Region (2017-2022)
    • 6.1.2 APAC Growth Hormone Disorder Treatment Revenue by Region (2017-2022)
  • 6.2 APAC Growth Hormone Disorder Treatment Sales by Type
  • 6.3 APAC Growth Hormone Disorder Treatment Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe Growth Hormone Disorder Treatment by Country
    • 7.1.1 Europe Growth Hormone Disorder Treatment Sales by Country (2017-2022)
    • 7.1.2 Europe Growth Hormone Disorder Treatment Revenue by Country (2017-2022)
  • 7.2 Europe Growth Hormone Disorder Treatment Sales by Type
  • 7.3 Europe Growth Hormone Disorder Treatment Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Growth Hormone Disorder Treatment by Country
    • 8.1.1 Middle East & Africa Growth Hormone Disorder Treatment Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa Growth Hormone Disorder Treatment Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa Growth Hormone Disorder Treatment Sales by Type
  • 8.3 Middle East & Africa Growth Hormone Disorder Treatment Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Growth Hormone Disorder Treatment
  • 10.3 Manufacturing Process Analysis of Growth Hormone Disorder Treatment
  • 10.4 Industry Chain Structure of Growth Hormone Disorder Treatment

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 Growth Hormone Disorder Treatment Distributors
  • 11.3 Growth Hormone Disorder Treatment Customer

12 World Forecast Review for Growth Hormone Disorder Treatment by Geographic Region

  • 12.1 Global Growth Hormone Disorder Treatment Market Size Forecast by Region
    • 12.1.1 Global Growth Hormone Disorder Treatment Forecast by Region (2023-2028)
    • 12.1.2 Global Growth Hormone Disorder Treatment Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Growth Hormone Disorder Treatment Forecast by Type
  • 12.7 Global Growth Hormone Disorder Treatment Forecast by Application

13 Key Players Analysis

  • 13.1 Teva Pharmaceutical Industries Ltd
    • 13.1.1 Teva Pharmaceutical Industries Ltd Company Information
    • 13.1.2 Teva Pharmaceutical Industries Ltd Growth Hormone Disorder Treatment Product Offered
    • 13.1.3 Teva Pharmaceutical Industries Ltd Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Teva Pharmaceutical Industries Ltd Main Business Overview
    • 13.1.5 Teva Pharmaceutical Industries Ltd Latest Developments
  • 13.2 Amneal Pharmaceutical Inc
    • 13.2.1 Amneal Pharmaceutical Inc Company Information
    • 13.2.2 Amneal Pharmaceutical Inc Growth Hormone Disorder Treatment Product Offered
    • 13.2.3 Amneal Pharmaceutical Inc Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 Amneal Pharmaceutical Inc Main Business Overview
    • 13.2.5 Amneal Pharmaceutical Inc Latest Developments
  • 13.3 Mayne Pharma Group Limited
    • 13.3.1 Mayne Pharma Group Limited Company Information
    • 13.3.2 Mayne Pharma Group Limited Growth Hormone Disorder Treatment Product Offered
    • 13.3.3 Mayne Pharma Group Limited Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 Mayne Pharma Group Limited Main Business Overview
    • 13.3.5 Mayne Pharma Group Limited Latest Developments
  • 13.4 Merck KGaA
    • 13.4.1 Merck KGaA Company Information
    • 13.4.2 Merck KGaA Growth Hormone Disorder Treatment Product Offered
    • 13.4.3 Merck KGaA Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 Merck KGaA Main Business Overview
    • 13.4.5 Merck KGaA Latest Developments
  • 13.5 Sanofi
    • 13.5.1 Sanofi Company Information
    • 13.5.2 Sanofi Growth Hormone Disorder Treatment Product Offered
    • 13.5.3 Sanofi Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 Sanofi Main Business Overview
    • 13.5.5 Sanofi Latest Developments
  • 13.6 Sun Pharmaceutical Industries Ltd
    • 13.6.1 Sun Pharmaceutical Industries Ltd Company Information
    • 13.6.2 Sun Pharmaceutical Industries Ltd Growth Hormone Disorder Treatment Product Offered
    • 13.6.3 Sun Pharmaceutical Industries Ltd Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.6.4 Sun Pharmaceutical Industries Ltd Main Business Overview
    • 13.6.5 Sun Pharmaceutical Industries Ltd Latest Developments
  • 13.7 Novartis AG
    • 13.7.1 Novartis AG Company Information
    • 13.7.2 Novartis AG Growth Hormone Disorder Treatment Product Offered
    • 13.7.3 Novartis AG Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.7.4 Novartis AG Main Business Overview
    • 13.7.5 Novartis AG Latest Developments
  • 13.8 F. Hoffmann-La Roche Ltd
    • 13.8.1 F. Hoffmann-La Roche Ltd Company Information
    • 13.8.2 F. Hoffmann-La Roche Ltd Growth Hormone Disorder Treatment Product Offered
    • 13.8.3 F. Hoffmann-La Roche Ltd Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.8.4 F. Hoffmann-La Roche Ltd Main Business Overview
    • 13.8.5 F. Hoffmann-La Roche Ltd Latest Developments
  • 13.9 Abbott
    • 13.9.1 Abbott Company Information
    • 13.9.2 Abbott Growth Hormone Disorder Treatment Product Offered
    • 13.9.3 Abbott Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.9.4 Abbott Main Business Overview
    • 13.9.5 Abbott Latest Developments
  • 13.10 PT. Daewoong Pharmaceutical Company
    • 13.10.1 PT. Daewoong Pharmaceutical Company Company Information
    • 13.10.2 PT. Daewoong Pharmaceutical Company Growth Hormone Disorder Treatment Product Offered
    • 13.10.3 PT. Daewoong Pharmaceutical Company Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.10.4 PT. Daewoong Pharmaceutical Company Main Business Overview
    • 13.10.5 PT. Daewoong Pharmaceutical Company Latest Developments
  • 13.11 Genentech, Inc
    • 13.11.1 Genentech, Inc Company Information
    • 13.11.2 Genentech, Inc Growth Hormone Disorder Treatment Product Offered
    • 13.11.3 Genentech, Inc Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.11.4 Genentech, Inc Main Business Overview
    • 13.11.5 Genentech, Inc Latest Developments
  • 13.12 Bausch Health Companies Inc
    • 13.12.1 Bausch Health Companies Inc Company Information
    • 13.12.2 Bausch Health Companies Inc Growth Hormone Disorder Treatment Product Offered
    • 13.12.3 Bausch Health Companies Inc Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.12.4 Bausch Health Companies Inc Main Business Overview
    • 13.12.5 Bausch Health Companies Inc Latest Developments
  • 13.13 Lilly
    • 13.13.1 Lilly Company Information
    • 13.13.2 Lilly Growth Hormone Disorder Treatment Product Offered
    • 13.13.3 Lilly Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.13.4 Lilly Main Business Overview
    • 13.13.5 Lilly Latest Developments
  • 13.14 Ipsen Pharma
    • 13.14.1 Ipsen Pharma Company Information
    • 13.14.2 Ipsen Pharma Growth Hormone Disorder Treatment Product Offered
    • 13.14.3 Ipsen Pharma Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.14.4 Ipsen Pharma Main Business Overview
    • 13.14.5 Ipsen Pharma Latest Developments
  • 13.15 Ferring B.V
    • 13.15.1 Ferring B.V Company Information
    • 13.15.2 Ferring B.V Growth Hormone Disorder Treatment Product Offered
    • 13.15.3 Ferring B.V Growth Hormone Disorder Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.15.4 Ferring B.V Main Business Overview
    • 13.15.5 Ferring B.V Latest Developments

14 Research Findings and Conclusion

Growth hormone disorder is a rare type of condition that is typically characterized by inadequate secretion of growth hormone (GH) from the anterior pituitary gland. This kind of hormones can be present since birth and cause serious genetic mutation or structural defects in the brain. The growth hormone disorders can be acquired in the later years due to the presence of severe infection, trauma among others. The risk of passing the abnormal gene from affected parent to offspring is 50% for each pregnancy.

The global market for Growth Hormone Disorder Treatment is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Growth Hormone Disorder Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Growth Hormone Disorder Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Growth Hormone Disorder Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Growth Hormone Disorder Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Growth Hormone Disorder Treatment players cover Teva Pharmaceutical Industries Ltd, Amneal Pharmaceutical Inc, Mayne Pharma Group Limited, Merck KGaA and Sanofi, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Growth Hormone Disorder Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Growth Hormone Disorder Treatment market, with both quantitative and qualitative data, to help readers understand how the Growth Hormone Disorder Treatment market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.

Market Segmentation:
The study segments the Growth Hormone Disorder Treatment market and forecasts the market size by Type (Growth Hormone Stimulator and Growth Hormone Inhibitor,), by Application (Dwarfism, Gigantism and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Growth Hormone Stimulator
Growth Hormone Inhibitor

Segmentation by application
Dwarfism
Gigantism
Other

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Teva Pharmaceutical Industries Ltd
Amneal Pharmaceutical Inc
Mayne Pharma Group Limited
Merck KGaA
Sanofi
Sun Pharmaceutical Industries Ltd
Novartis AG
F. Hoffmann-La Roche Ltd
Abbott
PT. Daewoong Pharmaceutical Company
Genentech, Inc
Bausch Health Companies Inc
Lilly
Ipsen Pharma
Ferring B.V

Chapter Introduction
Chapter 1: Scope of Growth Hormone Disorder Treatment, Research Methodology, etc.
Chapter 2: Executive Summary, global Growth Hormone Disorder Treatment market size (sales and revenue) and CAGR, Growth Hormone Disorder Treatment market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Growth Hormone Disorder Treatment sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Growth Hormone Disorder Treatment sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Growth Hormone Disorder Treatment market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Teva Pharmaceutical Industries Ltd, Amneal Pharmaceutical Inc, Mayne Pharma Group Limited, Merck KGaA, Sanofi, Sun Pharmaceutical Industries Ltd, Novartis AG, F. Hoffmann-La Roche Ltd and Abbott, etc.
Chapter 14: Research Findings and Conclusion
Buy now